| Greetings!
We’re excited to announce that Level 3 of our New Drug Submission (NDS) Training Series is now open for registration!
Building on the advanced concepts covered in Level II, Level 3 takes you even deeper into the complexities of preparing New Drug Submissions (NDS) in CTD and eCTD formats for Health Canada. This workshop will focus on advanced dossier structuring, post-market submission requirements, detailed guidance on Health Canada's Module 1, and best practices for managing regulatory requests, including responses to Health Canada inquiries and reconsideration requests.
This session is tailored for experienced regulatory affairs professionals, quality assurance specialists, and individuals managing complex submissions. If you have completed Level II or have significant experience with CTD/eCTD dossier preparation, this is your next step toward mastering regulatory filings and lifecycle management.
Registration closes May 23, 2025 — don’t miss your chance to complete your NDS training journey with AAPS Pharma!
If you have any questions, feel free to contact us at events@aapspharma.com. We look forward to continuing your professional growth journey! | 
No comments:
Post a Comment